Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase IIb study ZYN002 in adult with refractory focal epilepsy.

X
Trial Profile

Phase IIb study ZYN002 in adult with refractory focal epilepsy.

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 14 Jan 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cannabidiol (Primary)
  • Indications Partial epilepsies
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Dec 2018 According to the Zynerba Pharmaceuticals media release, the Company has decided to postpone the initiation of this trial until after reporting data from the four childhood neuropsychiatric studies.
    • 09 Jan 2018 New trial record
    • 03 Jan 2018 According to the Zynerba Pharmaceuticals media release, company intends to initiate this trial in the second half of 2018. The design of this study will be modified from the STAR 1 and STAR 2 trial design which includes increase in the number of patients enrolled, baseline seizure frequency, length of the study and also changes in randomization methodologies utilized.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top